Efavirenz

Efavirenz is an essential medication in the treatment of HIV infection, specifically used as part of highly active antiretroviral therapy (HAART). It is a non-nucleoside reverse transcriptase inhibitor (NNRTI), meaning it works by blocking the HIV virus’s ability to replicate inside human cells.
Efavirenz is often prescribed alongside two other antiretroviral drugs, forming a combination therapy to achieve optimal viral suppression and improve the overall health of those living with HIV. The medication helps reduce the amount of HIV in the blood and prevents the virus from progressing to AIDS.
One important aspect of Efavirenz is its long-lasting effect, with a single dose typically administered once daily, regardless of food intake. It is important to follow the prescribed dosing regimen to ensure the drug’s efficacy and to prevent the development of drug resistance.
Patient safety is paramount, and individuals using Efavirenz should be closely monitored for any potential side effects or adverse reactions. Common side effects may include dizziness, drowsiness, headaches, and sleep disturbances. While these side effects may be uncomfortable, they typically subside with time and do not require discontinuation of the medication.